ATORVASTATINE ARROW GENERIQUES 40 mg, film-coated tablet 30 tablets, CIP 3400930112427
Active ingredients: Atorvastatin, Atorvastatin calcium trihydrate
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet30 tablets, CIP 3400930112427orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ATORVASTATINE ARROW GENERIQUES 40 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC polyéthylène PVDC aluminium de 30 comprimé(s)
- Marketing authorisation holder
- ARROW GENERIQUES
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 7 Apr 2020
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67607954CIP73011242CIP133400930112427Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ATORVASTATINEcomprimé | 40 mg · un comprimé | FT |
| ATORVASTATINE CALCIQUE TRIHYDRATÉEcomprimé | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.